Evaluating the Supportive Care Costs of Severe Radiochemotherapy-lnduced Mucositis and Pharyngitis : Results From a Northwestern University Costs of Cancer Program Pilot Study With Head and Neck and Nonsmall Cell Lung Cancer Patients Who Received Care at a County Hospital, a Veterans Administration Hospital, or a Comprehensive Cancer Care Center

Saved in:
Bibliographic Details
Published inCancer Vol. 113; no. 6; pp. 1446 - 1452
Main Authors NONZEE, Narissa J, DANDADE, Neal A, MARKOSSIAN, Talar, AGULNIK, Mark, ARGIRIS, Athanassios, PATEL, Jyoti D, KERN, Robert C, MUNSHI, Hidayatullah G, CALHOUN, Elizabeth A, BENNETT, Charles L
Format Journal Article
LanguageEnglish
Published New York, NY Wiley-Liss 15.09.2008
Subjects
Biological and medical sciences
Drug toxicity and drugs side effects treatment
Medical sciences
Pharmacology. Drug treatments
Toxicity: respiratory system, ent, stomatology
Tumors
United States
North America
America
Antineoplastic agent
Toxicity
Lung cancer
non-small cell lung carcinoma
Chemoradiotherapy
Cancerology
ENT disease
Bronchus disease
Complication
head and neck
Pharynx disease
Veteran
Public health
Human
Lung disease
Mucositis
Respiratory disease
Hospitalization
Malignant tumor
Radiotherapy
Chemotherapy
Treatment
Health economy
Radiation injury
Head and neck cancer
Supportive care
Combined treatment
Mucosa disease
Economic aspect
Pharyngitis
Cost analysis
Cancer
Online AccessGet full text

Cover

More Information
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.23714